Psychedelics and the Texas Trip: Three Part Series
After years of struggling with PTSD and traumatic brain injuries, former SEAL Team 6 member Marcus Capone found hope in psychedelic therapy. His journey, alongside unexpected advocates like former Texas Governor Rick Perry, is reshaping the conversation on mental health treatment for veterans. In a special three-part series, Psychedelics and the Texas Trip, Texas Public Radio explores the groundbreaking efforts to fund clinical trials for psychedelics as a treatment for PTSD.
- 3.11.2025
- News
Boulder Weekly: BIFF marches on Four picks to make the most of this year’s fest
The Boulder International Film Festival (BIFF) returns for its 21st year, offering a diverse lineup of films that promise to captivate audiences. This year's festival highlights include The Friend, a heartfelt drama featuring Naomi Watts and Bill Murray; The White House Effect, a gripping archival documentary on climate policy; In Waves and War, an exploration of psychedelic therapy for veterans; and One to One: John & Yoko, a deep dive into John Lennon’s final concert. With over 60 films to discover, BIFF continues to celebrate storytelling in all its forms.
- 3.10.2025
- News
The Microdose: New California bills focus on veterans; the State of Psychedelics; Death penalty for dealers?
California is advancing new legislation aimed at supporting veterans and exploring the therapeutic potential of psychedelics. These bills seek to enhance mental health treatment options for veterans by potentially decriminalizing certain psychedelic substances and funding research into their efficacy for conditions like PTSD. Advocacy groups, such as the Heroic Hearts Project, have been instrumental in promoting these initiatives, emphasizing the need for alternative therapies
- 3.10.2025
- News
CBS News: With RFK Jr. in charge, supplement makers see chance to cash in
As Robert F. Kennedy Jr. takes charge of the Department of Health and Human Services, supplement makers see a major opportunity to expand their influence. With his skepticism of pharmaceutical regulation and a push for "health freedom," the industry aims to make bolder claims, secure government subsidies, and loosen FDA oversight. Advocates praise the shift, while critics warn of the risks posed by unproven treatments.
- 2.12.2025
- News
Salon: A psychedelic plant from Africa holds promise for addiction and trauma — but it's not for everyone.
Despite being illegal in the U.S., ibogaine popularity is growing. Here's why this shrub can potentially heal